Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. by Salagianni, M, Galani, I, Lundberg, A, Davos, C, Varela, A, Gavriil, A, Lyytikäinen, L, Lehtimäki, T, Sigala, F, Folkersen, L, Gorgoulis, V, Lenglet, S, Montecucco, F, Mach, F, Hedin, U, Hansson, G, Monaco, C, Andreakos, E

Toll-like receptor 7 protects from atherosclerosis by constraining inflammatory macrophage activation by Salagianni, M, Galani, I, Lundberg, A, Davos, C, Varela, A, Gavriil, A, Lyytikäinen, L, Lehtimäki, T, Sigala, F, Folkersen, L, Gorgoulis, V, Lenglet, S, Montecucco, F, MacH, F, Hedin, U, Hansson, G, Monaco, C, Andreakos, E

Vaccine breakthrough hypoxemic COVID-19 pneumonia in patients with auto-Abs neutralizing type I IFNs by Bastard, P, Vazquez, SE, Liu, J, Laurie, MT, Wang, CY, Gervais, A, Le Voyer, T, Le Voyer, T, Bizien, L, Zamecnik, C, Philippot, Q, Rosain, J, Catherinot, E, Willmore, A, Mitchell, AM, Bair, R, Garçon, P, Kenney, H, Fekkar, A, Salagianni, M, Poulakou, G, Siouti, E, Sahanic, S, Tancevski, I, Weiss, G, Nagl, L, Manry, J, Duvlis, S, Arroyo-Sánchez, D, Paz Artal, E, Rubio, L, Perani, C, Bezzi, M, Sottini, A, Quaresima, V, Roussel, L, Vinh, DC, Reyes, LF, Garzaro, M, Hatipoglu, N, Boutboul, D, Tandjaoui-Lambiotte, Y, Borghesi, A, Aliberti, A, Cassaniti, I, Venet, F, Monneret, G, Halwani, R, Sharif-Askari, NS, Danielson, J, Constantinescu, S